Overview

  • Product name
    AKT (SGK) substrate peptide

Description

  • Nature
    Synthetic
  • Amino Acid Sequence
    • Sequence
      RPRAATF
    • Additional sequence information
      The AKT (SGK) substrate peptide sequence (RPRAATF) is based on the N-terminus of GSK3.

Specifications

Our Abpromise guarantee covers the use of ab204851 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Functional Studies

    HPLC

  • Form
    Lyophilised
  • Additional notes

    ab204851 (AKT peptide) can be utilized as a substrate for the following active protein kinases:

     

    ab60322 (Active human AKT2 full length protein)
    ab60324 (Active human AKT3 full length protein)

     

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Store at -20°C. Avoid freeze / thaw cycle.

  • Reconstitution
    Dilute peptide in 25mM Tris-HCL buffer (ph 7.5) to a final concentration of 1mg/ml

General Info

  • Relevance
    The AKT (SGK) substrate peptide sequence (RPRAATF) is based on the N-terminus of GSK3. It is used as a substrate for kinase assays.

References for AKT (SGK) substrate peptide (ab204851)

ab204851 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab204851.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up